CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Increased ERCC Expression Correlates with Improved Outcome of Patients Treated with Cisplatin as an Adjuvant Therapy for Curatively Resected Gastric Cancer
Sun Kyung Baek, Si-Young Kim, Jae Jin Lee, Yoon Wha Kim, Hwi Joong Yoon, Kyung Sam Cho
Cancer Research and Treatment. 2006;38(1):19-24.   Published online 2006 February 28    DOI: https://doi.org/10.4143/crt.2006.38.1.19

Excel Download

Increased ERCC Expression Correlates with Improved Outcome of Patients Treated with Cisplatin as an Adjuvant Therapy for Curatively Resected Gastric Cancer
Cancer Research and Treatment. 2006;38(1):19   Crossref logo
Link1 Link2

6543 A phase II study of adjuvant chemotherapy with docetaxel, capecitabine and cisplatin in patients with curatively resected stage IIIb and IV advanced gastric cancer
European Journal of Cancer Supplements. 2009;7(2):374   Crossref logo
Link1 Link2

Immunochemotherapy with OK-432 may improve survival for people with curatively resected gastric cancer☆☆☆★Abstracted from: Sakamoto J, Teramukai S, Nakazato H et al. Efficacy of adjuvant immunochemotherapy with OK-432 for patients with curatively resected gastric cancer: a meta-analysis of centrally randomized controlled clinical trials. Journal of Immunotherapy 2002; 25: 405–12.
Cancer Treatment Reviews. 2003;29(1):73-75   Crossref logo
Link1 Link2

Cost-effectiveness of adjuvant chemotherapy for curatively resected gastric cancer with S-1
BMC Cancer. 2013;13(1):   Crossref logo
Link1 Link2 Link3

Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB–IV gastric cancer
Gastric Cancer. 2015;20(1):182-189   Crossref logo
Link1 Link2 Link3 Link4

Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer
Lung Cancer. 2005;49(1):85-94   Crossref logo
Link1 Link2

Efficacy of adjuvant chemotherapy using tegafur-based regimen for curatively resected gastric cancer: update of a meta-analysis
International Journal of Clinical Oncology. 2009;14(2):85-89   Crossref logo
Link1 Link2 Link3

Dihydropyrimidine dehydrogenases and cytidine-deaminase gene polymorphisms as outcome predictors in resected gastric cancer patients treated with fluoropyrimidine adjuvant chemotherapy
Journal of Surgical Oncology. 2008;98(2):130-134   Crossref logo
Link1 Link2

Low Thymidylate Synthase Expression in the Primary Tumor Predicts Favorable Clinical Outcome in Resected Gastric Cancer Patients Treated with Adjuvant Tegafur
Oncology. 2004;66(3):226-233   Crossref logo
Link1 Link2

Interpretation the Results of Adjuvant Chemotherapy in Curatively Resected Pancreatic Cancer
Annals of Oncology. 2019;30:vi78   Crossref logo
Link1 Link2 Link3 Link4

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.